To evaluate whether the inhibitory effect of tamoxifen on proliferation was influenced by SIRT4, we compared the relative viability of breast cancer cells under a tamoxifen concentration approximately equal to the IC50. This evidence concerns the gene SIRT4 and breast carcinoma.